Product

Berlim 25/20 Association

Aliases

BERLIM 25/20 ASSOCIATION

1 clinical trial

1 indication

Indication

Dyslipidemia Associated With Type II Diabetes Mellitus

Clinical trial

National, Multicenter, Randomized, Double-blind, Triple-dummy, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.

Status: Recruiting, Estimated PCD: 2025-04-01